GlassScriptPhysician profile
Matthew Sather
NPI 1356736920
$35,138.30
in general payments reported to CMS, 2019-2025
6 companies · $1,016 in 2025
The $1,016 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $9,079 · 2022: $18K · 2023: $4,310 · 2024: $2,449 · 2025: $1,016.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,359 · Food and Beverage: $1,847 · Grant: $1,500 · Education: $68.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,358.84 |
| Food and Beverage | $1,846.73 |
| Grant | $1,500.00 |
| Education | $68.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,337.85 | 2021-2024 | Micra, Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $11,068.54 | 2021-2024 | Watchman Flx, Vigilant X4 Crt-D |
| Abbott Laboratories | $5,676.22 | 2022-2025 | Ensite Precision, Tacticath Ablation Catheter, Sensor Enabled, Ensite |
| Philips North America LLC | $1,782.91 | 2022-2025 | Igt Devices Undivided, (Bs2) Lm Undivided, (Am5) Lead Management |
| Biotronik INC. | $248.46 | 2021-2022 | |
| Biosense Webster, INC. | $24.32 | 2024 | Carto 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Sather listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.